Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

作者：M.C. Hosseinipour, L. Cottle, A.Y. Liu, R. Kofron, D. Burns, S. Li, C.W. Hendrix, A.R. Rinehart, Joe Eron, P. Richardson, S.H. Eshleman, A. Adeyeye, B. Grinsztejn, R.J. Landovitz, M. Magnus, M.A. Marzinke, R. Panchia, G. Chau, M.S. Cohen, M. McCauley, D. Margolis, H. Dawood · 发表于：UNC Libraries · 年份：2023 · DOI：10.17615/2t00-0w43 · 研究领域：Hepatitis C virus research、HIV/AIDS drug development and treatment、HIV Research and Treatment